Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Fang-Yu Liu Ph.D. | Founder & Chairman | -- | -- | -- |
| Mr. Toshiyo Chen | GM & Director | -- | -- | -- |
| Ms. Chi-Yu Yang | VP of Finance & Accounting Supervisor | -- | -- | -- |
| Dr. Guo-Chun Song Ph.D. | Chief Technology Officer | -- | -- | -- |
| Mr. Stephen Douglas Cary M.B.A. | Senior Vice President of Business Development | -- | -- | -- |
Handa Pharmaceuticals, Inc.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Handa Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States and China. The company offers ONCORE, a proprietary drug delivery technology that was developed to improve the patient compliance and safety of the tyrosine kinase inhibitor of oncology drugs; Tascenso ODT for the treatment of multiple sclerosis; and HND-033 and HND-027 for oncology diseases. It also provides Quetiapine XR to treat Schizophrenia; Dexlansoprazole DR capsules to treat erosive esophagitis and heartburn associated with symptomatic non-erosive gastroesophageal reflux disease; HND-004 for treating diabetes; HND-032 for smoking cessation; and HND-026, a GI drug. The company was founded in 2014 and is headquartered in Tainan City, Taiwan.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
April 18, 2024 at 12:00 AM UTC
Ex-Dividend Date